CWM
BMY.RT

Connecticut Wealth Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Connecticut Wealth Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,508
Closed -$248K – 215
2020
Q4 		$248K Buy
+4,508
New +$9.6K 0.03% 162
2020
Q3 		– Sell
-4,624
Closed -$243K – 206
2020
Q2 		$243K Buy
+4,624
New +$16.7K 0.03% 129

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Connecticut Wealth Management's BMY.RT Position: Q1 2021 in Review

Connecticut Wealth Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 4,508 shares — an estimated $248K sold.

Connecticut Wealth Management first reported a position in BMY.RT in Q2 2020 and held it in 2 quarters. The position peaked at $248K in Q4 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Connecticut Wealth Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Connecticut Wealth Management sold 4,508 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $248K.
  • Connecticut Wealth Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020 and held it in 2 quarters.
  • Connecticut Wealth Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $248K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Connecticut Wealth Management's 13F filing for Q1 2021, filed 29 Apr 2021.